Citation: G. Treiber et al., AMOXICILLIN METRONIDAZOLE/OMEPRAZOLE/CLARITHROMYCIN - A NEW, SHORT QUADRUPLE THERAPY FOR HELICOBACTER-PYLORI ERADICATION/, Helicobacter, 3(1), 1998, pp. 54-58
Citation: U. Klotz, EFFECT OF AGE ON PHARMACOKINETICS AND PHARMACODYNAMICS IN MAN, International journal of clinical pharmacology and therapeutics, 36(11), 1998, pp. 581-585
Citation: J. Keller et al., RELEASE PATTERNS OF 5-AMINOSALICYLIC ACID IN HUMAN SMALL-INTESTINE - IMPORTANCE OF GALENIC PREPARATION, Medizinische Klinik, 93(5), 1998, pp. 294-299
Citation: G. Li et al., STEREOSELECTIVE STEADY-STATE DISPOSITION AND ACTION OF PROPAFENONE INCHINESE SUBJECTS, British journal of clinical pharmacology, 46(5), 1998, pp. 441-445
Citation: K. Morike et al., VARIABILITY IN THE FREQUENCY OF CYTOCHROME P450-2D6 (CYP2D6) DEFICIENCY, British journal of clinical pharmacology, 46(1), 1998, pp. 87-87
Authors:
FROMM MF
DILGER K
BUSSE D
KROEMER HK
EICHELBAUM M
KLOTZ U
Citation: Mf. Fromm et al., GUT WALL METABOLISM OF VERAPAMIL IN OLDER-PEOPLE - EFFECTS OF RIFAMPICIN-MEDIATED ENZYME-INDUCTION, British journal of clinical pharmacology, 45(3), 1998, pp. 247-255
Authors:
GLEITER CH
KLOTZ U
KUHLMANN J
BLUME H
STANISLAUS F
HARDER S
PAULUS H
Citation: Ch. Gleiter et al., WHEN ARE BIOAVAILABILITY STUDIES REQUIRED - A GERMAN PROPOSAL, Journal of clinical pharmacology, 38(10), 1998, pp. 904-911
Citation: U. Klotz et E. Ammon, CLINICAL AND TOXICOLOGICAL CONSEQUENCES OF THE INDUCTIVE POTENTIAL OFETHANOL, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 7-12
Citation: K. Dilger et al., DO PROTON PUMP INHIBITORS (PPI) AFFECT THE DISPOSITION OF THEOPHYLLINE, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 24-24
Authors:
FRIEDRICH U
GRIESE U
SCHWAB M
FRITZ P
KLOTZ U
Citation: U. Friedrich et al., DETERMINATION OF TELOMERES IN DIFFERENT TISSUES OF ELDERLY PATIENTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4815-4815
Authors:
TREIBER G
WITTIG J
AMMON S
KEES F
DIWAN PV
WALKER S
KLOTZ U
Citation: G. Treiber et al., ERADICATION OF HELICOBACTER-PYLORI (HP) BY A NEW QUADRUPLE REGIMEN - EFFECTS OF AGE ON DRUG DISPOSITION AND CLINICAL EFFICACY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4924-4924
Authors:
TREIBER G
WITTIG J
AMMON S
WALKER S
KLOTZ U
Citation: G. Treiber et al., IMPACT OF AGE ON A NEW SHORT-TERM QUADRUPLE THERAPY FOR ERADICATION OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI), Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 616-616
Citation: G. Li et al., STEADY-STATE DISPOSITION, PHARMACODYNAMICS AND INTERACTIONS BETWEEN THE ENANTIOMERS OF PROPAFENONE IN CHINESE SUBJECTS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 645-645
Authors:
TREIBER G
WITTIG J
AMMON S
WALKER S
KLOTZ U
Citation: G. Treiber et al., NEW SHORT-TERM QUADRUPLE THERAPIES FOR ERADICATION OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) - MACLOR STUDY, Gastroenterology, 114(4), 1998, pp. 1277-1277
Authors:
KLOTZ U
HOENSCH H
SCHUTZ T
BEAUNE P
ZANGER U
BODE JC
FRITZ P
Citation: U. Klotz et al., EXPRESSION OF INTESTINAL DRUG-METABOLIZING-ENZYMES IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE, Current therapeutic research, 59(8), 1998, pp. 556-563
Authors:
PLATTEN HP
SCHWEIZER E
DILGER K
MIKUS G
KLOTZ U
Citation: Hp. Platten et al., PHARMACOKINETICS AND THE PHARMACODYNAMIC ACTION OF MIDAZOLAM IN YOUNGAND ELDERLY PATIENTS UNDERGOING TOOTH EXTRACTION, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 552-560
Citation: K. Morike et al., USE OF AMINOGLYCOSIDES IN ELDERLY PATIENTS - PHARMACOKINETIC AND CLINICAL CONSIDERATIONS, Drugs & aging, 10(4), 1997, pp. 259-277
Citation: G. Treiber et al., AGE-DEPENDENT ERADICATION OF HELICOBACTER-PYLORI WITH DUAL THERAPY, Alimentary pharmacology & therapeutics, 11(4), 1997, pp. 711-718
Citation: G. Treiber et al., AGE-DEPENDENT ERADICATION OF HELICOBACTER-PYLORI (HP) WITH DUAL THERAPY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 417-417
Authors:
RODER F
SCHWAB M
VOGGENREITER B
BERNER V
ALEKER T
MORIKE K
KLOTZ U
THON KP
Citation: F. Roder et al., BENZODIAZEPINE USE IN PATIENTS WITH FRACTURES OF THE PROXIMAL FEMUR -DETECTION IN SERUM VERSUS DRUG HISTORY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 448-448
Citation: K. Dilger et al., CYP2E1 PHENOTYPING IN PATIENTS WITH ALCOHOLIC LIVER-DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 452-452
Citation: E. Ammon et U. Klotz, IN-VITRO ASSESSMENT OF A POSSIBLE VERAPAMIL ETHANOL INTERACTION/, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 463-463
Citation: E. Eldesoky et al., DISPOSITION OF INTRAVENOUS THEOPHYLLINE IN ASTHMATIC-CHILDREN - BAYESIAN-APPROACH VS DIRECT PHARMACOKINETIC CALCULATIONS, Japanese Journal of Pharmacology, 75(1), 1997, pp. 13-20